With a unique heritage in dermatology as well as decades of cutting-edge innovation, Galderma is the leading company solely dedicated to advancing dermatology for every skin story. We are strategically positioned in attractive, consumer-driven segments of the dermatology market, characterized by high growth fundamentals. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
KEY FACTS ABOUT GALDERMA
3.417 B USD
audited 2021 net sales
employees in approx. 90 countries
employees work at our 4 manufacturing sites. We make 75% of our products in house.
healthcare providers worked with to serve all channels from DTC, online and retailers through an increasingly digital format
we operate from 50 sites in 40 countries, with our headquarters in Switzerland.
Find out about our leadership team by clicking here.
A timeline of our history
Foundation of Galderma as a joint venture between L’Oréal and Nestlé
Following the invention of the first Cetaphil formulation in 1947
Galderma discovers Adapalene
First commercial operations
Launch of Differin for acne treatment
Opening of our production site in Baie d’Urfé, Canada
Licensing agreement for Metvix (Skin cancer)
Opening of our production site in Hortolândia, Brazil
Launch of Differin 0.3%
Launch of Epiduo
Launch of Azzalure and Restylane Injector